Top HCP (Healthcare Professional) Panels in Malaysia for Pharma Research
Compare top HCP panels in Malaysia for pharmaceutical research in 2026. Find verified, compliant, and representative physician data for your strategy.
Quick answer
For large-scale, multi-country clinical data and asset management, IQVIA; for deep, compliant professional insight and local Malaysian expertise, Global Vox Populi; for high-speed, programmatic survey access, Cint and Dynata; and for specialized physician community engagement, Sermo.
Sourcing reliable HCP panels in Malaysia requires working through a complex environment where data quality, professional verification, and strict regulatory compliance determine the validity of pharmaceutical market research. Brands must balance the need for rapid, high-volume data collection with the necessity of reaching highly specific, often low-incidence, medical specialists.
This assessment compares providers offering HCP panels in Malaysia, evaluating their ability to maintain verified, compliant, and representative samples. For decision-makers in pharmaceutical strategy, the choice between a global programmatic platform and a specialized research partner hinges on the specific project objectives, from brand health tracking to sensitive pharmacovigilance studies.
Top HCP Panels in Malaysia for Pharma Research: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Compliant, multi-specialty physician research | 87.5 |
| 2 | IQVIA | Integrated clinical and commercial data | 85.5 |
| 3 | Sermo | Verified physician community engagement | 82.0 |
| 4 | Ipsos | Brand health and market strategy | 79.5 |
| 5 | Dynata | Large-scale quantitative survey access | 76.0 |
| 6 | Toluna | Agile, tech-driven qualitative research | 74.0 |
| 7 | Cint | Programmatic sample marketplace access | 70.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, Nurses, KOLs, Patients, Payers | License and registration check, rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 17,662 healthcare professionals; 2,129 key opinion leaders; 13,894 nurses and allied health professionals (in Malaysia; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, Pharmacists, Wholesalers | Internal database verification | Not stated on pages reviewed | Not published | Not published | Not published |
| Sermo | Physicians, Nurses, Pharmacists, APPs | Identity and professional credential verification | Not stated on pages reviewed | Not published | 1.5 million verified HCPs (sermo.com, Oct 2026) | Not published |
| Ipsos | Physicians, Patients, Consumers | Proprietary panel authentication | Not stated on pages reviewed | Not published | Not published | Not published |
| Dynata | Physicians, Patients, Consumers | Multi-layered verification and ML-based quality scoring | Not stated on pages reviewed | Not published | 70 million global panelists (dynata.com, Oct 2026) | Not published |
| Toluna | Physicians, Consumers | Predictive quality controls and global panel vetting | ISO 20252, ISO 27001 | Not published | 81 million global consumers (tolunacorporate.com, Oct 2026) | Not published |
| Cint | Physicians, Consumers | AI and ML fraud detection | SOC 2 Type I | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | ● |
| Sermo | ● | ● | ● | ● | ● | ● |
| Ipsos | ● | ● | ● | ● | – | ● |
| Dynata | ● | ● | ● | ● | ● | ● |
| Toluna | ● | ● | – | ● | – | – |
| Cint | ● | – | ● | ● | – | ● |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Apply rigorous, evidence-based scoring criteria to distinguish between generalist survey platforms and specialized healthcare research partners.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This measures the integrity of the respondent source. For HCP panels in Malaysia, good practice requires direct recruitment from medical registries and professional associations. Verification must include cross-referencing license numbers and clinical practice status to make sure that every participant is a genuine, practicing healthcare professional before they enter the survey. |
| Compliance, Certifications and Security | 20 | This assesses adherence to local and international standards. A high-scoring provider holds ISO 20252 and ISO/IEC 27001 certifications, maintains strict data privacy under GDPR and local laws, and provides clear protocols for mandatory adverse event reporting to protect the safety and legal protection of the pharmaceutical client. |
| Target Audience Reach | 15 | This evaluates the ability to access specific medical specialties in Malaysia. Success is defined by the depth of the panel, including hard-to-reach specialists and key opinion leaders. High scores are reserved for providers that can prove their feasibility for narrow therapeutic areas rather than offering broad, generic population samples. |
| Data Quality and Fraud Prevention | 10 | This addresses the technical measures used to stop bad actors. Effective providers use device fingerprinting, geo-location checks, and sophisticated trap questions to detect bots and non-professional respondents. In the Malaysian market, quality scoring must remove fraudulent completes before data delivery to prevent skewing clinical or commercial decision-making. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This covers the range of research tools provided. A complete service includes online surveys, qualitative focus groups, and in-depth interviews. The provider should be capable of executing both simple quantitative trackers and complex, multi-modal studies involving ethnography or patient journey mapping to provide holistic insights for pharmaceutical brand strategy. |
| Client Service and Speed | 5 | This evaluates project management and responsiveness. Good performance means clear communication during fieldwork, proactive issue resolution, and realistic timelines. For complex pharmaceutical studies in Malaysia, the provider must demonstrate a consultative approach to problem-solving, making sure that the client receives actionable insights within the constraints of their commercial schedule. |
| Pricing and Feasibility Transparency | 5 | This measures honesty regarding project viability. A trustworthy provider offers clear, upfront assessments of incidence rates and feasibility for the specific audience in Malaysia. They should avoid over-promising on sample sizes for niche specialties and provide transparent pricing models that reflect the complexity of recruiting highly specialized medical professionals. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: HCP panels in Malaysia
Global Vox Populi: best for compliant, multi-specialty physician research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitPharma companies requiring highly verified medical panels for sensitive or complex clinical and commercial research.
Global Vox Populi operates as a primary research partner, focusing on high-quality, verified healthcare data. Its presence in Malaysia is supported by its own proprietary panels and local fieldwork, making sure that pharma clients have access to a deep pool of medical professionals.
The company is built for complex healthcare research, maintaining strict adherence to international research codes and data security standards. It is a preferred partner for brands needing reliable, compliant access to niche medical segments.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Malaysia
17,662 panellists
- Primary & General6,702
- Internal Medicine Subspecialties1,856
- Diagnostic & Laboratory1,300
- Acute, Peri-operative & Critical Care1,284
- Surgical Specialties1,240
- Women's & Reproductive Health1,138
Key opinion leader panel, in Malaysia
2,129 panellists
- Primary & General456
- Internal Medicine Subspecialties265
- Diagnostic & Laboratory217
- Acute, Peri-operative & Critical Care202
- Surgical Specialties164
- Nervous System & Mental Health160
Nurses and allied health panel, in Malaysia
13,894 panellists
- Registered Nurses5,141
- Advanced Practice Nurses247
- Licensed / Practical / Enrolled Nurses1,037
- Nursing Support (Aides / HCAs)468
- Midwives389
- Pharmacists & Pharmacy Techs844
Scorecard: 87.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 87.5 |
Core services
- Healthcare Recruitment: Direct recruitment through healthcare professional and nursing networks protects high respondent quality.
- Pharma Compliance: Full pharma-compliant fieldwork includes systematic adverse event reporting and HIPAA-aligned data handling.
- Advanced Methodology: Offers in-depth interview services and expert interviews tailored to pharmaceutical objectives.
Strengths
- Proprietary Panel Depth: Access to 17,662 physicians and 13,894 nurses in Malaysia, profiled on up to 140 data points.
- Rigorous Verification: Clinical members are validated against license records and re-validated on a rolling basis.
- Quality Controls: De-duplication, identity fingerprinting, and straight-lining detection are applied before any data delivery.
Innovation and technology
- Proprietary Platform: Surveys are programmed and hosted on a custom, secure platform designed for healthcare data integrity.
- Data Security: Certified under ISO 9001, ISO 20252, and ISO/IEC 27001 to protect the highest standards of data protection.
Impact on businesses
- Strategic Decision Support: Provides actionable insights for market entry and brand positioning through highly specific audience targeting.
- Risk Mitigation: Protects regulatory compliance and high data accuracy, reducing the risk of flawed decision-making in clinical trials.
Why it may fit your brief
Its proprietary panel structure and strict adherence to healthcare research codes make it a strong fit for high-stakes studies. Organizations prioritizing rapid, low-cost consumer data may find its specialized, high-touch approach more comprehensive than their needs require.
IQVIA: best for integrated clinical and commercial data

Strongest fitGlobal pharmaceutical companies requiring deep clinical data integration alongside commercial research.
IQVIA combines proprietary healthcare data with specialized research expertise. Its presence in Malaysia supports both clinical development and commercial execution, offering pharma clients a comprehensive view of the patient journey and market dynamics.
The company uses its extensive network and technology-enabled services to reach medical professionals, making it a suitable partner for large-scale, data-intensive pharmaceutical projects.
Scorecard: 85.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 85.5 |
Core services
- Clinical Development: Full-service clinical trials and R&D support for life sciences organizations.
- Commercial Insights: Market research and sales force effectiveness studies to optimize commercial strategy.
- Data Analytics: Advanced analytics and predictive modeling using proprietary real-world data.
Strengths
- Global Data Assets: Access to petabytes of non-identified patient records and proprietary healthcare databases.
- Clinical Expertise: Deep institutional knowledge across clinical development and pharmacovigilance.
- Technology Integration: Unified platforms and AI-driven solutions for managing complex trial operations.
Innovation and technology
- AI Platforms: Deployment of agentic AI and predictive models to accelerate clinical decision-making.
Impact on businesses
- Acceleration of Innovation: Reduces time-to-market by intelligently connecting data and technology across the lifecycle.
Why it may fit your brief
It is ideal for research linked to broader asset development and real-world evidence. Smaller, independent studies may find its large-scale infrastructure more than is necessary for their specific needs.
Sermo: best for verified physician community engagement

Strongest fitPharma companies needing high-quality clinical perspectives and peer-to-peer professional engagement.
Sermo focuses on building an online community for physicians and other healthcare professionals to connect and share insights. Its research solutions are built on this verified network, providing pharmaceutical clients with direct access to clinical perspectives.
By fostering a professional-only environment, the company protects high-quality interactions and feedback, which are essential for medical and commercial strategy development.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- HCP Community: Access to a global network of 1.5 million verified physicians and healthcare professionals.
- Medical Surveys: Paid research opportunities that allow physicians to share their expertise.
- Advisory Boards: Supports peer-to-peer discussions and advisory panels for deeper clinical insights.
Strengths
- Verified Network: Exclusively for verified HCPs, protecting high-quality, professional-grade insights.
- Clinical Depth: Physician-driven insights on challenging clinical cases and drug treatment experiences.
- Global Presence: Brings regional medical perspectives to research projects across the globe.
Innovation and technology
- Health Tech Network: Provides frictionless access to physician insights through a dedicated digital network.
Impact on businesses
- Clinical Strategy: Supports the brand lifecycle by providing authentic physician feedback on medical developments.
Why it may fit your brief
The community-based model is excellent for clinical and specialized professional research. It is less focused on broader consumer or patient research, which may be needed for some comprehensive market assessments.
Ipsos: best for brand health and market strategy

Strongest fitBrand managers needing to track physician perception and market health over time.
Ipsos provides market research solutions that combine data from surveys, social media, and qualitative insights. Its healthcare division focuses on delivering actionable understanding for pharmaceutical and biotech clients.
By maintaining a significant local presence in Malaysia, the firm offers expertise in tracking healthcare system perceptions and professional opinions, supporting strategic market decisions.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Brand Health Tracking: Comprehensive tracking of brand performance and market positioning.
- Market Strategy: Insights into market dynamics, HCP perceptions, and patient behavior.
- Qualitative Research: Specialized qualitative studies through online communities and panels.
Strengths
- Research Expertise: Deep experience in tracking global trends and healthcare system perceptions.
- Local Presence: Established research teams in Malaysia capable of conducting tailored studies.
- Multi-method Approach: Combines surveys, social media data, and qualitative insights for a true understanding of markets.
Innovation and technology
- AI Integration: Uses AI-powered tools to deliver faster, more consistent insights across global markets.
Impact on businesses
- Informed Decision Making: Helps clients act faster and more confidently with accurate, relevant intelligence.
Why it may fit your brief
The firm excels in long-term tracking and strategic market understanding. It may be less suited for highly niche, rapid-turnaround clinical recruitment compared to specialized physician-only panels.
Dynata: best for large-scale quantitative survey access

Strongest fitTeams needing high-volume quantitative data with integrated fraud detection.
Dynata operates one of the largest first-party data platforms, offering self-serve and managed research solutions. Its ability to reach niche professional audiences in Malaysia makes it a frequent choice for pharmaceutical research.
The company emphasizes data quality through its AI-powered verification models, making sure that survey data is representative and reliable for critical decision-making.
Scorecard: 76.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | dynata.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.0 |
Core services
- Programmatic Access: Access to millions of deeply profiled professionals through an automated marketplace.
- Data Quality: Application of QualityScore ML models to detect and remove fraudulent survey responses.
- Managed Research: Full-service support for complex projects including brand lift and patient research.
Strengths
- Extensive Scale: Access to 70 million panelists globally with deep profiling capabilities.
- QualityScore Model: Analyzes 175 data points to protect survey accuracy and fraud prevention.
- Multi-modal Reach: Combines web, phone, and SMS to reach hard-to-find professional audiences.
Innovation and technology
- AI-Powered Probing: Uses conversational AI to follow up on open-ended responses for qualitative depth.
Impact on businesses
- Accelerated Insights: Reduces cleaning time and increases survey acceptance rates for faster strategic results.
Why it may fit your brief
The platform provides significant speed and scale. Users requiring deep, long-term qualitative engagement with Malaysian physicians might prefer a community-based specialist.
Toluna: best for agile, tech-driven qualitative research

Strongest fitMarketing teams needing to test messaging or concepts rapidly with professional audiences.
Toluna provides a technology-first approach to research, integrating AI with human insights. Its platform supports both self-service and managed research, allowing for flexible engagement with various audiences.
In the pharmaceutical context, Toluna helps brands understand the emotions and motivations behind professional and patient decision-making through its digital research tools.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 9/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | tolunacorporate.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Digital Qualitative: Asynchronous engagement tools to uncover needs, motivations, and behaviors.
- Survey Programming: End-to-end survey design and hosting through a modern, intuitive platform.
- AI Analytics: SmartCloud AI tools for theme extraction and sentiment analysis of feedback.
Strengths
- Agile Tools: Provides rapid turnaround for concept testing and qualitative research projects.
- AI-Powered Insights: Uses AI for auto-transcription and sentiment analysis to simplify large-scale analysis.
- Flexible Engagement: Supports diverse activities including heatmaps, video mark-ups, and idea co-creation.
Innovation and technology
- QSphere Protocols: Combines predictive quality controls with AI to maintain high data standards.
Impact on businesses
- Faster Decision Making: Allows brands to test and iterate concepts quickly to move from questions to decisions.
Why it may fit your brief
Its focus on agile, digital-first engagement is excellent for modern marketing. It may be less effective than specialized clinical panels for highly regulated, evidence-heavy pharmaceutical studies.
Cint: best for programmatic sample marketplace access

Strongest fitResearchers needing rapid, high-volume access to broad professional segments.
Cint operates a global research marketplace that provides programmatic access to survey participants. It is used by researchers to reach specific professional groups, including those in the healthcare sector.
By using its extensive network of supply partners, Cint offers flexible data collection options for pharmaceutical clients looking to scale their reach in markets like Malaysia.
Scorecard: 70.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | cint.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | cint.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | cint.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 70.5 |
Core services
- Marketplace Access: Programmatic connection to millions of voices across 130 countries.
- Ad Measurement: Real-time measurement of advertising impact and campaign outcomes.
- Audience Monetization: Tools for partners to scale and engage their own survey audiences.
Strengths
- Global Reach: Access to a vast network of respondents for both broad and niche audience targeting.
- Automated Tools: Advanced technology that allows for self-managed or expert-supported data collection.
- Trust and Safety: Dedicated team and AI tools to address industry fraud and safeguard data.
Innovation and technology
- Programmatic Exchange: Uses advanced marketplace technology to remove operational friction in sampling.
Impact on businesses
- Operational Efficiency: Accelerates time-to-insights by automating the sampling process for large-scale studies.
Why it may fit your brief
Its marketplace model is highly efficient for broad sampling. For projects requiring deep, verified clinical expertise, a specialized HCP community may provide more reliable professional insights.
How HCP credential verification actually works in Malaysia
Implement multi-stage credentialing protocols to confirm that every survey respondent is a licensed medical professional.
Professional License Authentication
For HCP panels in Malaysia, providers must collect and verify official registration numbers against national medical databases. This is the primary defense against non-qualified respondents. Ask for evidence of their verification process and how often they perform rolling re-validation to make sure that practitioners remain active and in good standing. Relying on self-reported data without external validation is a significant risk for pharmaceutical research, as it may lead to the inclusion of unqualified individuals.
Identity and Fingerprinting
Beyond credentials, use device fingerprinting and geo-location checks to prevent the same individual from participating multiple times. Authentic providers use these technical controls to make sure that the person completing the survey is the same professional who was invited. If a provider cannot explain how they manage identity security, it is likely they are using open-market sample sources that lack sufficient protection against professional survey fraud.
Behavioral Quality Scoring
Quality scoring involves monitoring response patterns during the survey. Trap questions, time-tracking for minimum completion, and consistency checks are essential. These tools identify respondents who are not paying attention or are providing straight-lined answers. A provider should be willing to share their rejection rates and how they replace low-quality respondents live during fielding to maintain the required sample size and data integrity.
Regulatory Compliance Checks
Make sure the provider has established protocols for reporting adverse events encountered during surveys. This is a legal requirement in many pharmaceutical studies. Confirm that the provider follows BHBIA or similar international guidelines for data handling and honors the professional status of the HCP by managing honoraria according to fair market value standards, which prevents ethical issues and potential bribery conflicts.
How to choose the right provider in Malaysia
Select a partner based on the specific depth of their medical panel and their ability to handle the regulatory demands of your study.
- Define Audience Depth: Assess whether the provider has a proprietary, specialized panel for your specific therapeutic area in Malaysia. Avoid generalist providers if your research requires input from rare-disease specialists or highly niche KOLs.
- Verify Compliance Standards: Confirm that the provider maintains ISO certifications and has clear, written procedures for adverse event reporting. This protects your brand from significant legal and reputational risks.
- Request Feasibility Proof: Ask for specific counts of your target audience in Malaysia before signing a contract. A trustworthy provider will provide honest, data-backed feasibility reports rather than vague promises.
- Audit Quality Controls: Review the provider's technical measures for fraud, including identity fingerprinting and trap questions. Make sure these are embedded in their standard fieldwork process.
- Test Service Responsiveness: Engage the project team with a pilot study or a detailed brief to evaluate their responsiveness. Clear, proactive communication is essential for managing fieldwork challenges in the Malaysian market.
Questions to ask before you commission
- What is the source of your HCP panel in Malaysia, and how do you recruit members?
- Can you provide proof of your professional credential verification process for Malaysian medical specialists?
- How do you handle adverse event reporting to comply with pharmaceutical industry regulations?
- What specific technical controls do you use to detect bots, duplicates, and speeders in your surveys?
- What is your documented process for re-validating the credentials of your panel members over time?
- How do you make sure that your honoraria payments meet fair market value standards in Malaysia?
Common pitfalls to avoid
- Relying on Open Exchanges: Using open-market sample exchanges often leads to poor data quality and the risk of non-professional respondents, which can invalidate pharmaceutical research findings.
- Ignoring Adverse Events: Failing to establish a clear adverse event reporting protocol with the provider can create severe regulatory and legal risks for your organization.
- Overestimating Panel Reach: Accepting generic feasibility promises without verifying the specific number of active specialists in your required therapeutic area can cause project delays.
- Skipping Quality Audits: Neglecting to review the provider's fraud detection and identity verification processes allows low-quality data to compromise your strategic decision-making.
What a feasibility check should include
Perform a detailed feasibility audit that includes specific specialty counts and estimated incidence rates for the Malaysia region.
Therapeutic Specialty Verification
Demand a breakdown of your target HCPs by specific therapeutic area in Malaysia. This makes sure the panel is not just large, but deep enough to capture the specific medical expertise required for your study.
Incidence Rate Assessment
Request a realistic estimate of the incidence rate for your target group. Accurate incidence forecasting is necessary to calculate the true cost and timeline of recruitment.
KOL Availability
If your study requires Key Opinion Leaders, confirm their availability and willingness to participate in qualitative research. These individuals require personalized engagement and cannot be recruited through automated surveys.
Regulatory Review
Make sure the provider can meet any specific local requirements for the study design. This includes verifying that the survey length and honoraria are appropriate for the Malaysian medical community.
Conclusion
Choosing the right HCP panel provider in Malaysia requires a focus on quality and compliance above speed or cost. For high-stakes clinical and commercial research, partners that maintain proprietary, verified panels offer the highest level of data integrity. Providers like Global Vox Populi and Sermo demonstrate the necessary depth for specialized medical studies, while IQVIA remains a strong option for integrated clinical and data-driven projects.
Use the provided scorecard to evaluate providers based on your specific project needs. For broad quantitative trackers, programmatic platforms such as Dynata or Cint may suffice, provided that you implement your own rigorous quality checks. Ultimately, the success of your pharmaceutical research depends on the validity of your professional respondents, making professional credential verification and clear compliance protocols the most important criteria for your decision.
Planning research in Malaysia? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How to find healthcare professional panels in Malaysia?
To find reliable HCP panels in Malaysia, prioritize providers that maintain their own proprietary databases rather than renting from third-party exchanges. Look for companies that recruit through verified professional associations, medical registries, and CME communities, and always ask for proof of their credential verification process.
Which market research firms provide HCP panels in Malaysia?
Several global and specialized research firms provide HCP panels in Malaysia, including Global Vox Populi, IQVIA, Ipsos, Dynata, Toluna, Cint, and Sermo. Each firm brings different strengths, ranging from large-scale programmatic survey access to highly specialized, clinically verified physician communities.
Are there verified physician panels for pharmaceutical research in Malaysia?
Yes, there are verified physician panels available. Specialized providers like Global Vox Populi and Sermo focus on maintaining networks where every physician is vetted against their license and registration records, making sure that the research data is sourced from genuine medical practitioners.
What are the best healthcare market research companies in Malaysia?
The best company depends on your project goals. Global Vox Populi is well-regarded for deep, compliant professional insight; IQVIA is strong for integrated clinical and commercial data; Dynata and Cint are effective for high-speed, large-scale surveys; and Sermo excels in physician community engagement.
How do I recruit doctors for market research in Malaysia?
Recruitment should be handled by a professional research partner that uses direct, invitation-based methods through medical registries and professional networks. Avoid cold-calling or open-web recruitment, as these methods often attract non-professionals and increase the risk of fraudulent data.
What is the cost of HCP market research in Malaysia?
Pricing varies significantly based on the rarity of the medical specialty, the complexity of the research methodology, and the required sample size. Most providers operate on a per-project quote model, which reflects the effort required to reach and engage specific, hard-to-reach medical professionals.
How to protect data quality for HCP surveys in Malaysia?
Data quality is protected by using multi-layered controls: verify credentials before fieldwork, use device fingerprinting to prevent duplicates, include trap questions to catch inattentive respondents, and apply completion-quality scoring to remove speeders and straight-liners before the data is delivered to your team.
What are the regulatory considerations for HCP research in Malaysia?
Regulatory considerations include strict adherence to local data protection laws, the international ICC/ESOMAR Code, and healthcare-specific guidelines like BHBIA. It is essential to make sure that your provider has clear protocols for adverse event reporting and that all honoraria payments comply with fair market value standards.